A new oncology treatment company dubbed Spesana is emerging out of stealth mode with a new molecular diagnostic decision support tool.
The platform is able to take information from a number of sources and synthesize information for providers. The way it works is Spesana’s tech can collect molecular diagnostic reports and coordinate them with EHRs, prior authorizations, payer processing, approved...
